| Market revenue in 2023 | USD 313.0 million |
| Market revenue in 2030 | USD 428.8 million |
| Growth rate | 4.6% (CAGR from 2023 to 2030) |
| Largest segment | Pain management |
| Fastest growing segment | Nutritional Supplements |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormone Replacement Therapy, Pain Management, Dermatology, Specialty Drugs, Nutritional Supplements, Other Therapeutic Areas |
| Key market players worldwide | Walgreens Boots Alliance Inc, Fresh Tracks Therapeutics Inc, Fagron SA, Albertsons Companies Inc Class A, Aurora Cannabis Inc, Trxade Health Inc, Specialist Pharmacy, Galenic, Apollo Hospitals Enterprise, Formul8, Fusion Apothecary |
Publish Date: -
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Walgreens Boots Alliance Inc | View profile | 331,000 | 108 Wilmot Road, Deerfield, IL, United States, 60015 | www.walgreensbootsalliance.com |
| Fresh Tracks Therapeutics Inc | View profile | 4 | 2000 Central Avenue, Suite 100, Boulder, CO, United States, 80301 | www.frtx.com |
| Fagron SA | View profile | 3,567 | Fascinatio Boulevard 350, Rotterdam, ZH, Netherlands, 3065 WB | www.fagron.com |
| Albertsons Companies Inc Class A | View profile | 285,000 | 250 Parkcenter Boulevard, Boise, ID, United States, 83706 | www.albertsonscompanies.com |
| Aurora Cannabis Inc | View profile | 1,130 | 3498 63 Avenue, Leduc, AB, Canada, T9E 0G8 | www.auroramj.com |
| Trxade Health Inc | View profile | 8 | 2420 Brunello Trace, Lutz, FL, United States, 33558 | www.trxadehealth.com |
| Specialist Pharmacy | View profile | 11-50 | Dagenham, Barking and Dagenham, United Kingdom, Europe | specialist-pharmacy.com/ |
| Galenic | View profile | - | Boulogne-billancourt, Ile-de-France, France, Europe | galenic.com |
| Apollo Hospitals Enterprise | View profile | 10001+ | Chennai, Tamil Nadu, India, Asia | www.apollohospitals.com |
| Formul8 | View profile | 11-50 | Singapore, Central Region, Singapore, Asia | formul8.com/ |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Compounding Pharmacies Market Outlook will help companies and investors design strategic landscapes.
Pain Management was the largest segment with a revenue share of 33.26% in 2023.
Horizon Databook has segmented the U.K. compounding pharmacies market based on hormone replacement therapy, pain management, dermatology, specialty drugs, nutritional supplements, other therapeutic areas covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Compounding Pharmacies Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Compounding Pharmacies Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
